TVTX- Travere Therapeutics, Inc.

Name: Travere Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Dube Eric M	432.9K	$22.53M	-
Other	Heerma Peter	138.6K	$7.21M	-
Other	Rote William E.	123.1K	$6.41M	-
CFO	Cline Christopher R.	116.9K	$6.08M	-
Other	Inrig Jula	111.5K	$5.80M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 10, 2023	Reed Elizabeth E58	SVP, GC &Corporate Secretary	Sell	825	$16.59	$13,686.75	-1.4%	-4.8%	-59.5%
May 10, 2023	Rote William E.58	Senior Vice President, R&D	Sell	825	$16.59	$13,686.75	-1.4%	-4.8%	-59.5%
Apr 11, 2023	Cline Christopher R.50	Chief Financial Officer	Sell	47	$21.49	$1,010.03	-	-25.8%	-68.2%
Feb 2, 2023	Calvin Sandra60	SVP, Chief Accounting Officer	Sell	2,031	$21.87	$44,418.79	-2.3%	-29.4%	-62.4%
Feb 1, 2023	Reed Elizabeth E58	SVP, GC &Corporate Secretary	Sell	2,590	$22.25	$57,627.50	-4.3%	-29.2%	-61.1%
Feb 1, 2023	Rote William E.58	Senior Vice President, R&D	Sell	2,590	$22.25	$57,627.50	-4.1%	-29.2%	-61.1%
Feb 1, 2023	Heerma Peter53	Chief Commercial Officer	Sell	1,779	$21.75	$38,696.81	-2.1%	-29.2%	-61.1%
Feb 1, 2023	Dube Eric M57	Chief Executive Officer	Sell	8,196	$22.25	$182,361.00	-3.3%	-29.2%	-61.1%
Feb 1, 2023	Cline Christopher R.50	Chief Financial Officer	Sell	1,588	$21.75	$34,542.18	-3.0%	-29.2%	-61.1%
Jan 25, 2023	Calvin Sandra60	SVP, Chief Accounting Officer	Sell	1,097	$21.86	$23,976.44	-1.5%	-1.9%	-57.2%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC